CLOSE
CLOSE
Investor Relations
And information
HomeInvestor Relations› Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences to Acquire Total Ankle Replacement (Salto Talaris(R)) and Silastic Toe Replacement (Futura(TM)) Product Portfolios From Tornier N.V.
PLAINSBORO, N.J. and AMSTERDAM, The Netherlands , Sept. 3, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) and Tornier N.V. (NASDAQ:TRNX), today announced a definitive agreement under which Integra will acquire the United States rights to Tornier's Salto Talaris®
View HTML
Toggle Summary Tornier Reports Second Quarter 2015 Results
Upper Extremity Constant Currency Growth of 11.9% Led by the Aequalis Ascend™ Flex AMSTERDAM, Netherlands , Aug. 5, 2015 (GLOBE NEWSWIRE) -- Tornier N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reported today its
View HTML
Toggle Summary Tornier to Report Second Quarter 2015 Financial Results on August 5, 2015
AMSTERDAM, The Netherlands , July 29, 2015 (GLOBE NEWSWIRE) -- Tornier N.V. (NASDAQ:TRNX), a global medical device company focused on providing solutions to orthopaedic extremity surgeons, announced today that it will report financial results for the second quarter ended June 28, 2015 after the
View HTML
Toggle Summary Wright Medical and Tornier Shareholders Approve All Proposals Related to Merger
Transaction Expected to Close in Third Quarter of 2015, Subject to Receipt of Clearance by FTC MEMPHIS, Tenn. and AMSTERDAM, The Netherlands , June 18, 2015 (GLOBE NEWSWIRE) -- Wright Medical Group, Inc. (Nasdaq:WMGI) and Tornier N.V. (Nasdaq:TRNX) today announced that all proposals related to the
View HTML
Toggle Summary Tornier Reports First Quarter 2015 Results and Provides Updated 2015 Outlook
Upper extremity constant currency growth of 14.0% led by Aequalis Ascend® Flex™ Total extremities constant currency revenue growth of 9.2% Adjusted gross margin increased by 220 basis points to 77.3% AMSTERDAM, The Netherlands , May 5, 2015 (GLOBE NEWSWIRE) -- Tornier N.V.
View HTML
Toggle Summary Tornier Announces First Quarter 2015 Conference Call
AMSTERDAM, The Netherlands, April 15, 2015 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing solutions to orthopaedic extremity surgeons, announced today that it will report financial results for the first quarter ended March 29, 2015 after the
View HTML
Toggle Summary Tornier Announces U.S. FDA Clearance of Simpliciti(TM) Shoulder System
New Class of Ultra Short-Stem Total Shoulder Arthroplasty Will Increase Access to Treatment for Patients With Compromised Shoulder Function and Severe Pain AMSTERDAM, The Netherlands , March 10, 2015 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on
View HTML
Toggle Summary Tornier Reports Fourth Quarter and Full Year 2014 Results and Provides 2015 Outlook
Fourth quarter revenue increased 14.1% over prior year quarter, in constant currency Upper extremity constant currency revenue growth of 22.1% led by Aequalis Ascend Flex Full year adjusted gross margin increased by 180 basis points to 76.0% AMSTERDAM, The Netherlands , Feb.
View HTML
Toggle Summary Tornier Announces Fourth Quarter and Fiscal Year 2014 Conference Call
AMSTERDAM, The Netherlands , Feb. 4, 2015 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing solutions to orthopaedic extremity surgeons, announced today that it will report financial results for the fourth quarter and full year ended December 28,
View HTML
Toggle Summary Tornier Announces Preliminary Fourth Quarter and Full Year 2014 Revenue
Fourth Quarter Revenue Increases 11.3% to $92.8 Million Full Year 2014 Revenue of $345.4 Million Represents 11.1% Growth Fourth Quarter Extremities Revenue Grew 16.0% in Constant Currency Over Prior Year AMSTERDAM, The Netherlands , Jan. 12, 2015 (GLOBE NEWSWIRE) -- Tornier N.V.
View HTML
Toggle Summary Tornier to Present at Piper Jaffray 26th Annual Healthcare Conference
November 19, 2014 AMSTERDAM, The Netherlands , Nov. 19, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's President and Chief Executive
View HTML
Toggle Summary Tornier to Present at Piper Jaffray 26th Annual Healthcare Conference
AMSTERDAM, The Netherlands , Nov. 19, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's President and Chief Executive Officer, and Shawn
View HTML
Toggle Summary Tornier Reports Third Quarter 2014 Results
Revenue increased 14.0% over prior year quarter, in constant currency Upper extremity constant currency revenue growth of 20.0% led by Aequalis Ascend Flex Entered into definitive merger agreement with Wright Medical Group on October 27 to create premier high-growth extremities-biologics company
View HTML
Toggle Summary Wright Medical Group, Inc. and Tornier N.V. Agree to Merge Creating Premier High-Growth Extremities-Biologics Company
October 27, 2014 Combination Will Offer Comprehensive Upper and Lower Extremity Product Portfolio and Broad Global Reach Further Accelerates Growth Opportunities in Three of the Fastest Growing Areas in Orthopaedics Adds Significant Scale and Scope to Provide Accelerated Path to Profitability and
View HTML
Toggle Summary Tornier Announces Third Quarter 2014 Revenue and Increases 2014 Revenue Guidance
AMSTERDAM, The Netherlands , Oct. 27, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, today announced revenue for the third quarter ended September 28, 2014 .
View HTML
Toggle Summary Tornier Announces Third Quarter 2014 Conference Call
AMSTERDAM, The Netherlands , Oct. 22, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the third quarter ended September 28,
View HTML
Toggle Summary Tornier Reports Second Quarter 2014 Results
Revenue increased 9.5% over prior year quarter, in constant currency Upper extremity constant currency revenue growth of 11.4% led by Aequalis Ascend Flex Increases full year revenue and EBITDA guidance AMSTERDAM, The Netherlands , Aug. 7, 2014 (GLOBE NEWSWIRE) -- Tornier N.V.
View HTML
Toggle Summary Tornier Announces Second Quarter 2014 Conference Call
AMSTERDAM, The Netherlands , July 10, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the second quarter ended June 29, 2014
View HTML
Toggle Summary Tornier to Present at the Bank of America Merrill Lynch 2014 Health Care Conference
AMSTERDAM, The Netherlands , May 8, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's President and Chief Executive Officer, and Shawn
View HTML
Toggle Summary Tornier Reports First Quarter 2014 Results
Revenue increased 6.8% over prior year quarter, in constant currency Upper extremity constant currency revenue growth of 9.9% led by Aequalis Ascend Flex U.S. distribution transition progressing from sales force alignment to optimization AMSTERDAM, The Netherlands , May 6, 2014 (GLOBE NEWSWIRE) --
View HTML
Toggle Summary Tornier Announces First Quarter 2014 Conference Call
AMSTERDAM, The Netherlands , April 16, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the first quarter ended March 30, 2014
View HTML
Toggle Summary Tornier Announces Secondary Offering of Ordinary Shares
AMSTERDAM, Netherlands , Feb. 24, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today the commencement of a proposed underwritten public offering of 5,125,000 ordinary
View HTML
Toggle Summary Tornier Reports Fourth Quarter and Fiscal Year 2013 Results and Provides 2014 Outlook
Phase 1 of U.S. distribution channel transition complete; Phase 2 underway, with focus on sales force optimization and training New product launches and pipeline on track, led by Aequalis Ascend Flex adoption and expected second quarter launch of Aequalis Reversed in Japan AMSTERDAM, The
View HTML
Toggle Summary Tornier to Present at the 2014 RBC Capital Markets Global Healthcare Conference
AMSTERDAM, The Netherlands , Feb. 10, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's President and Chief Executive Officer, and Shawn
View HTML
Toggle Summary Tornier Announces Fourth Quarter and Full Year 2013 Conference Call
AMSTERDAM, The Netherlands , Feb. 4, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the fourth quarter and full year ended
View HTML
Toggle Summary Tornier Announces Preliminary Fourth Quarter and Full Year 2013 Revenue
Fourth Quarter Revenue Expected to Increase by 5.1% to 6.3% to $83 to $84 Million AMSTERDAM, The Netherlands , Jan. 13, 2014 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today
View HTML
Toggle Summary Tornier to Present at 32nd Annual J.P. Morgan Healthcare Conference
AMSTERDAM, The Netherlands , Dec. 30, 2013 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's President and Chief Executive Officer, and Shawn
View HTML
Toggle Summary Tornier to Present at Piper Jaffray 25th Annual Healthcare Conference
AMSTERDAM , Nov. 20, 2013 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's President and Chief Executive Officer, and Shawn McCormick , the
View HTML
Toggle Summary Tornier Reports Third Quarter 2013 Results
U.S. distribution channel transition accelerates with agreements covering 61% of U.S. revenue Non-GAAP gross margin improved to 74.2% Aequalis Ascend Flex ™ launch tracking to plan; over 120 trained surgeon users AMSTERDAM, The Netherlands , Nov. 5, 2013 (GLOBE NEWSWIRE) -- Tornier N.V.
View HTML
Toggle Summary Tornier Announces Third Quarter 2013 Conference Call
AMSTERDAM , Oct. 10, 2013 (GLOBE NEWSWIRE) -- Tornier N.V. (Nasdaq:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the third quarter ended September 29, 2013 after the
View HTML
Toggle Summary Tornier Reports Second Quarter 2013 Results
Achieves Double-Digit Upper Extremity Product Category Growth Improves Non-GAAP Gross Margin Sequentially and Quarter over Quarter to 73.9% Expands OrthoHelix Product Line Reach with First International Sale AMSTERDAM , Aug. 6, 2013 (GLOBE NEWSWIRE) -- Tornier N.V.
View HTML
Toggle Summary Tornier Announces Second Quarter 2013 Conference Call
July 15, 2013 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the second quarter ended June 30, 2013 after the market
View HTML
Toggle Summary Tornier Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Underwriters' Over-Allotment Option
May 15, 2013 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today the closing of the previously announced underwritten public offering of 8.05 million ordinary shares
View HTML
Toggle Summary Tornier Announces Pricing of Public Offering of Ordinary Shares
May 9, 2013 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today the pricing of a previously announced underwritten registered public offering of 7.0 million ordinary
View HTML
Toggle Summary Tornier Reports First Quarter 2013 Results
May 7, 2013 Reiterates Revenue and Non-GAAP Adjusted EBITDA Outlook for 2013 Non-GAAP Adjusted Gross Margin Expands 200 Basis Points Year over Year, Excluding Acquisition Related Costs AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing
View HTML
Toggle Summary Tornier Announces Follow-on Offering of Ordinary Shares
Maay 7, 2013 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it has commenced an underwritten public offering of 7.0 million ordinary shares.
View HTML
Toggle Summary Tornier to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
April 26, 2013 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's President and Chief Executive Officer, and Shawn McCormick , the
View HTML
Toggle Summary Tornier Announces First Quarter 2013 Conference Call
April 3, 2013 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the first quarter ended March 31, 2013 after the market
View HTML
Toggle Summary Tornier Names David H. Mowry President and Chief Executive Officer
February 21, 2013 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that its Board of Directors has appointed David H.
View HTML
Toggle Summary Tornier Reports Fourth Quarter and Fiscal Year 2012 Results and Provides 2013 Outlook
February 21, 2013 OrthoHelix Acquisition Closed and Integration Proceeding Smoothly Adjusted EBITDA Margin Improves for both Fourth Quarter and Full Year AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic
View HTML
Toggle Summary Tornier to Present at the 2013 RBC Capital Markets Global Healthcare Conference
February 11, 2013 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's Interim President and Chief Executive Officer, and Shawn
View HTML
Toggle Summary Tornier Announces 2012 Fourth Quarter and Full Year Conference Call
January 22, 2013 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the fourth quarter and full year ended December 31,
View HTML
Toggle Summary Tornier Reiterates Fourth Quarter and Full Year 2012 Revenue Guidance
January 7, 2013 Full Financial Results Available on February 21, 2013; Company to Present at J.P. Morgan Healthcare Conference on January 7, 2013  AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic
View HTML
Toggle Summary Tornier to Present at the 31st Annual J.P. Morgan Healthcare Conference
December 18, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's Interim President and Chief Executive Officer, and Shawn
View HTML
Toggle Summary Tornier to Present at the 24th Annual Piper Jaffray Healthcare Conference
November 15, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's Interim President and Chief Executive Officer, and Shawn
View HTML
Toggle Summary Tornier Appoints David H. Mowry as Interim President and Chief Executive Officer
November 12, 2012 Medical Device Industry Veteran Kevin C. O'Boyle Named Interim Vice Chairman AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, today announced the appointment of
View HTML
Toggle Summary Tornier Reports Third Quarter 2012 Financial Results
November 5, 2012 Shoulder Products Drive Extremities Constant Currency Growth of 7% OrthoHelix Acquisition Provides Significant New Growth Opportunity AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic
View HTML
Toggle Summary Tornier to Present at the Credit Suisse 2012 Healthcare Conference
November 1, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's Chief Operating Officer, and Shawn McCormick , the Company's
View HTML
Toggle Summary Tornier Announces Third Quarter 2012 Conference Call
October 17, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the third quarter and nine months ended September 30,
View HTML
Toggle Summary Tornier to Acquire OrthoHelix Surgical Designs
August 24, 2012 Acquisition Is Expected to More Than Double Tornier's Lower Extremity Revenue Transaction Will Bring Innovative Technologies, High Growth, and Strong Gross Margins AMSTERDAM & MEDINA, Ohio --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on
View HTML
Toggle Summary Tornier Reports Second Quarter 2012 Financial Results
August 7, 2012 Shoulder Products Drive Extremities Constant Currency Growth of 8% Adjusted EBITDA Margin Improves Year Over Year for 4th Consecutive Quarter  AMSTERDAM, The Netherlands --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical
View HTML
Toggle Summary Tornier Appoints New Chief Financial Officer
July 18, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it has appointed Shawn T McCormick as Chief Financial Officer, effective as of September 4,
View HTML
Toggle Summary Tornier Announces Second Quarter 2012 Conference Call
July 17, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the second quarter and six months ended June 30, 2012
View HTML
Toggle Summary Ernst & Young Announces Tornier President & CEO Douglas Kohrs is the Master Entrepreneur Of The Year 2012 Award Winner for the Upper Midwest
June 20, 2012 Award Recognizes Entrepreneurial Excellence in Healthcare Category MINNEAPOLIS --(BUSINESS WIRE)-- Tornier, Inc. , the U.S. operating subsidiary of Tornier NV (NASDAQ: TRNX) announced that Douglas W. Kohrs , President and CEO of Tornier , a global medical device company focused on
View HTML
Toggle Summary Tornier to Present at the Wells Fargo Securities Research and Economics 2012 Healthcare Conference
June 12, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that David Mowry , the Company's Chief Operating Officer, and Carmen Diersen , the Company's Chief
View HTML
Toggle Summary Tornier Reports First Quarter 2012 Financial Results
May 8, 2012 Strong International Sales Drive Global Extremities Constant Currency Growth of 11.4% AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, today reported its financial
View HTML
Toggle Summary Tornier to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
May 1, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that Doug Kohrs , the Company's President and Chief Executive Officer, and Carmen Diersen , the
View HTML
Toggle Summary Tornier Announces 2012 Facility Consolidations
April 13, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it plans to consolidate its facilities to drive operational productivity and to reduce annual
View HTML
Toggle Summary Tornier Announces First Quarter 2012 Conference Call
April 10, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the three months ended April 1, 2012 after the market
View HTML
Toggle Summary Tornier Reports 2011 Financial Results and Provides 2012 Outlook
February 23, 2012 Fourth Quarter Sales and Adjusted EBITDA Exceeded Guidance 2012 Outlook Includes Double-Digit Constant Currency Extremities Growth AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ:TRNX), a global medical device company focused on providing surgical solutions to orthopaedic
View HTML
Toggle Summary Tornier to Present at the 2012 RBC Capital Markets Healthcare Conference
February 21, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that Doug Kohrs , the Company's President and Chief Executive Officer, and Carmen Diersen , the
View HTML
Toggle Summary Tornier to Highlight Products and Education Programs at American Academy of Orthopedic Surgeons (AAOS) Meeting
February 8, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, today announced it will highlight a range of products and patient education programs at the American Academy of
View HTML
Toggle Summary Tornier Announces 2011 Fourth Quarter and Full Year Conference Call
January 27, 2012 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that it will report financial results for the three months and full year ended December 31, 2011
View HTML
Toggle Summary Tornier Announces Preliminary Fourth Quarter Sales Gain of 12.7% and Full Year 2011 Sales Gain of 14.9%
January 9, 2012 Preliminary Fourth Quarter Extremity Product Sales Expand by 17.5%  AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists announced preliminary unaudited sales of $69.0
View HTML
Toggle Summary Tornier to Present at the 30th Annual J.P. Morgan Healthcare Conference
December 23, 2011 AMSTERDAM --(BUSINESS WIRE)-- Tornier, N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, announced today that Doug Kohrs , the Company's President and Chief Executive Officer, and Carmen Diersen , the
View HTML
Toggle Summary Tornier Reports Third Quarter 2011 Financial Results
November 8, 2011 Extremity Product Sales Growth Reported at 15%, 12% Constant Currency AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, reported sales of $57.6 million for the
View HTML
Toggle Summary Tornier Announces Conference Call of Third Quarter Results
AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), announced today its third quarter 2011 conference call will be held on Tuesday, November 8, 2011 at 5:30 p.m. eastern time following a news release earlier that afternoon which will detail the Company's financial results.
View HTML
Toggle Summary Tornier Reports Second Quarter 2011 Financial Results
August 9, 2011 Extremity Product Sales Growth Reported at 19%, 14% Constant Currency; Sales and Adjusted EBITDA Guidance Maintained for 2011  AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity
View HTML
Toggle Summary Tornier Announces First Implant in U.S. Clinical Study for the Simpliciti™ Stemless Shoulder Joint Replacement System
August 2, 2011 Simpliciti System Also Recently Launched in Europe at Prestigious Annecy Shoulder Course AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ:TRNX), a leading global medical device company focused on serving extremities specialists who treat orthopaedic conditions of the shoulder,
View HTML
Toggle Summary Tornier Announces Conference Call of Second Quarter Results
July 13, 2011 AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ:TRNX), announced today its second quarter 2011 conference call will be held on Tuesday, August 9, 2011 at 5:30 p.m. eastern time following a news release earlier that afternoon which will detail the Company's financial results.
View HTML
Toggle Summary Tornier Announces Launch of the Aequalis™ Ascend™ Convertible Shoulder Implant System at the 28th Annual San Diego Shoulder Course
June 22, 2011 First Implant Performed in May by  Sumant Krishnan, M.D AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a leading global medical device company focused on serving extremities specialists who treat orthopaedic conditions of the shoulder, elbow, wrist, hand, ankle and foot,
View HTML
Toggle Summary Tornier Introduces Porous Coated Affiniti™ Stem for Shoulder Joint Replacement Surgery
May 19, 2011 MINNEAPOLIS --(BUSINESS WIRE)-- Tornier Inc. the operating subsidiary of Tornier N.V. (NASDAQ: TRNX), a leading global medical device company focused on serving extremities specialists who treat orthopedic conditions of the shoulder, elbow, wrist, hand, ankle and foot, today announced
View HTML
Toggle Summary Tornier Reports First Quarter 2011 Financial Results
May 9, 2011 Sales Growth of 12% Drives Adjusted EBITDA Increase of 94% Company Raises Guidance for 2011 Sales and Adjusted EBITDA AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists,
View HTML
Toggle Summary INSERTING and REPLACING Tornier Reports First Quarter 2011 Financial Results
May 9, 2011 Sales Growth of 12% Drives Adjusted EBITDA Increase of 94% Company Raises Guidance for 2011 Sales and Adjusted EBITDA  AMSTERDAM--(BUSINESS WIRE)-- Insert "Consolidated Statements of Operations" table before "Condensed Consolidated Balance Sheets" table previously omitted by Business
View HTML
Toggle Summary Announces Conference Call of First Quarter Results
AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), announced today its first quarter 2011 conference call will be held on Monday, May 9, 2011 at 5:00 p.m. eastern time following a news release earlier that afternoon which will detail the Company's financial results.
View HTML
Toggle Summary Tornier Announces Launch of BioFiber® Surgical Mesh for Tendon Repair at Arthroscopic Surgery Conference
April 14, 2011 BioFiber Expands Tornier Portfolio of Innovative Products for the Repair of Rotator Cuff and Other Tendon Injuries Tornier (NASDAQ: TRNX), a global leader in extremity orthopaedics, today announced the launch of its BioFiber ® Surgical Mesh for the repair of rotator cuff and other
View HTML
Toggle Summary Tornier Announces Exercise of Underwriters' Option to Purchase Additional Ordinary Shares in IPO
March 7, 2011 AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (the "Company") (Nasdaq: TRNX) announced today that the underwriters of its initial public offering exercised their option to purchase an additional 721,274 ordinary shares at a price of $19.00 per share (before underwriters' discounts and
View HTML
Toggle Summary Tornier Reports Financial Results for 2010 and Provides 2011 Outlook
March 1, 2011 Sales Growth of 13% in 2010 Drives Adjusted EBITDA Increase of 76% Extremity Product Lines Record 15% 2010 Growth AMSTERDAM, The Netherlands --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global medical device company focused on providing surgical solutions to orthopaedic
View HTML
Toggle Summary Tornier to Highlight Six New Products at American Academy of Orthopaedic Surgeons (AAOS) Meeting
February 15, 2011 EDINA, Minn. --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), a global leader in extremity orthopaedics, today announced it will highlight six new products at the American Academy of Orthopaedic Surgeons 2011 Annual Meeting ("AAOS") being held February 15-19 in San Diego, CA.
View HTML
Toggle Summary Tornier Announces Conference Call of Fourth Quarter and Year End 2010 Results
February 15, 2011 AMSTERDAM --(BUSINESS WIRE)-- Tornier N.V. (NASDAQ: TRNX), announced today its fourth quarter 2010 conference call will be held on Tuesday, March 1, 2011 at 5:00 p.m. eastern time following a news release earlier that afternoon which will detail the Company's financial results.
View HTML
Toggle Summary Tornier Prices Initial Public Offering
February 2, 2011 AMSTERDAM--(BUSINESS WIRE)-- Tornier N.V. (the “Company”) announced today the pricing of its initial public offering of 8,750,000 of the Company’s ordinary shares at a price to the public of $19.00 per share, all of which were offered by Tornier N.V.
View HTML